Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation

Digoxin use in patients with AF is associated with increased levels of endothelial and platelet activation. If digitalis activates endothelial cells and platelets at pharmacologic doses, use of digitalis in conditions such as AF could predispose to thrombosis and vascular events.